Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's LymphomaCraig H. Moskowitz, Andrew D. Zelenetz, Barrett H. Childs et al.|Journal of Clinical Oncology|1999Cited by 303
High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysisTarun Kewalramani, Craig H. Moskowitz, Joachim Yahalom et al.|Blood|2000Cited by 120